MetLife Investment Management’s Integral Ad Science IAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-44,048
Closed -$448K 2837
2025
Q3
$448K Hold
44,048
﹤0.01% 1857
2025
Q2
$366K Hold
44,048
﹤0.01% 1835
2025
Q1
$355K Sell
44,048
-873
-2% -$8.71K ﹤0.01% 1895
2024
Q4
$469K Buy
44,921
+4,123
+10% +$45.2K ﹤0.01% 1835
2024
Q3
$441K Hold
40,798
﹤0.01% 1848
2024
Q2
$397K Buy
40,798
+5,464
+15% +$52.3K ﹤0.01% 1854
2024
Q1
$352K Buy
35,334
+9,537
+37% +$127K ﹤0.01% 1876
2023
Q4
$371K Hold
25,797
﹤0.01% 1857
2023
Q3
$307K Buy
25,797
+6,037
+31% +$93.3K ﹤0.01% 1940
2023
Q2
$355K Hold
19,760
﹤0.01% 1919
2023
Q1
$282K Hold
19,760
﹤0.01% 2006
2022
Q4
$174K Hold
19,760
﹤0.01% 2334
2022
Q3
$143K Hold
19,760
﹤0.01% 2486
2022
Q2
$196K Hold
19,760
﹤0.01% 2330
2022
Q1
$273K Buy
19,760
+12,835
+185% +$219K ﹤0.01% 2154
2021
Q4
$154K Hold
6,925
﹤0.01% 2213
2021
Q3
$143K Buy
+6,925
New +$137K ﹤0.01% 2271

Other funds holding IAS

MetLife Investment Management's IAS Position: Q4 2025 in Review

MetLife Investment Management sold out of Integral Ad Science (IAS) in Q4 2025, closing a stake of 44,048 shares — an estimated $448K sold.

MetLife Investment Management first reported a position in IAS in Q3 2021 and held it in 17 quarters. The position peaked at $469K in Q4 2024. 2 funds tracked by Wall St. Rank hold IAS as of Q4 2025.

  • MetLife Investment Management reported no remaining Integral Ad Science position as of Q4 2025 after selling out during the quarter.
  • MetLife Investment Management sold 44,048 Integral Ad Science shares in Q4 2025, an estimated $448K.
  • MetLife Investment Management first reported a position in Integral Ad Science in Q3 2021 and held it in 17 quarters.
  • MetLife Investment Management's Integral Ad Science position peaked at $469K in Q4 2024.
  • 2 funds tracked by Wall St. Rank held Integral Ad Science as of Q4 2025.

Based on MetLife Investment Management's 13F filing for Q4 2025, filed 12 Feb 2026.